BlackRock
MIRA icon

BlackRock’s MIRA Pharmaceuticals MIRA Stock Holding History

BlackRock’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$120K Buy
112,346
+2,577
+2% +$3.23K ﹤0.01% 4920
2025
Q4 		$166K Hold
109,769
– – ﹤0.01% 4777
2025
Q3 		$149K Buy
+109,769
New +$159K ﹤0.01% 4742

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

BlackRock's MIRA Position: Q1 2026 in Review

BlackRock increased its MIRA Pharmaceuticals (MIRA) stake by 2.3% in Q1 2026, buying an estimated $3.23K and bringing the position to 112,346 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #4920.

BlackRock first reported a position in MIRA in Q3 2025 and has held it in 3 quarters since. The position peaked at $166K in Q4 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • BlackRock held 112,346 shares of MIRA Pharmaceuticals worth $120K as of Q1 2026.
  • BlackRock bought 2,577 MIRA Pharmaceuticals shares in Q1 2026, an estimated $3.23K.
  • MIRA Pharmaceuticals made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4920 holding.
  • BlackRock first reported a position in MIRA Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • BlackRock's MIRA Pharmaceuticals position peaked at $166K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.